Showing results (1-10 of 376) with videos related to
Sort By:
Pageof 38
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Role of etravirine in combination antiretroviral therapy]Pere DomingoRadiologic Clinics of North America|May 9, 2022
Pulmonary Infections in People Living with HIVTomás Franquet, Pere DomingoEnfermedades Infecciosas Y Microbiologia Clinica|February 18, 2011
[Management of antiretroviral drug toxicity]Pere Domingo, Fernando LozanoEnfermedades Infecciosas Y Microbiologia Clinica|April 11, 2015
[Safety profile of dolutegravir]Antonio Rivero, Pere DomingoExpert Opinion on Pharmacotherapy|March 26, 2011
Combination antiretroviral therapyPere Domingo, Francesc VidalEnfermedades Infecciosas Y Microbiologia Clinica|April 15, 2011
[Antiretroviral therapy for HIV infection]Fernando Lozano, Pere DomingoEnfermedades Infecciosas Y Microbiologia Clinica|November 21, 2013
[Data on rilpivirine in treatment-naïve patients. Lessons from ECHO, THRIVE and STaR]Pere Domingo, Esteban RiberaBiochimica Et Biophysica Acta|October 6, 2009
Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatmentFrancesc Villarroya, Pere Domingo, Marta GiraltBest Practice & Research. Clinical Endocrinology & Metabolism|June 14, 2011
Adipose tissue biology and HIV-infectionMarta Giralt, Pere Domingo, Francesc VillarroyaTrends in Pharmacological Sciences|February 1, 2005
Lipodystrophy associated with highly active anti-retroviral therapy for HIV infection: the adipocyte as a target of anti-retroviral-induced mitochondrial toxicityFrancesc Villarroya, Pere Domingo, Marta GiraltPageof 38